Brian Markison, Lantheus Holdings CEO
January 13, 2025 12:05 AM EST
R&D

Lan­theus to buy Life Mol­e­c­u­lar Imag­ing for $350M, net­ting Alzheimer's di­ag­nos­tic

Lei Lei Wu

News Reporter

Ra­dio­phar­ma­ceu­ti­cal mak­er Lan­theus Hold­ings plans to ac­quire Life Mol­e­c­u­lar Imag­ing for $350 mil­lion in a bid to build up its com­mer­cial Alzheimer’s di­ag­nos­tics busi­ness. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

GSK kicks off JPM deal­mak­ing with $1B+ buy­out of IDRx and its rare can­cer drug

J&J looks at po­ten­tial bid for In­tra-Cel­lu­lar — re­port

Bio­gen of­fers to buy out strug­gling neu­ro part­ner Sage Ther­a­peu­tics

Ex­clu­sive: Buck­ing gene edit­ing down­turn, Tune rais­es $175M to bring epi­ge­net­ic edit­ing to clin­ic

Post-Hoc: Big Phar­ma is los­ing the AI tal­ent war

Chas­ing the next wave of obe­si­ty drugs, Met­sera files for an IPO

A service from the Financial Times